UnknownNot Applicable

University of Houston Drug Abuse Research Development Program II

United States100 participantsStarted 2014-08-01

Plain-language summary

The study is examining the impact of a Virtual Reality Cue Exposure Therapy intervention on heroin cravings compared to Relapse Prevention Drug Education.

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Injection or Non-Injection heroin user, 3 or more years of heroin use, Hispanic/Latino Exclusion Criteria: * Non heroin user, non-Hispanic/Latino, younger than 18 or older than 64, treated with any medications having a potential effect on heroin craving, mood, or heroin cessation medications in the past 30 days; use of other prescription and non-prescription drugs that may affect participation; Fear of closed spaces or inability to wear VR goggles; Visual problems that effect viewing VR materials; History of seizures or seizure disorders; History of serious self-reported health problems; and women who are pregnant

What they're measuring

Self-reported reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks.

Lab-based reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks. These are monitored continuously every 10th of a second.

Lab-based reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks. These are monitored continuously every 10th of a second.

Lab-based reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks. These are monitored continuously every 10th of a second.

Trial details

NCT IDNCT03557632

SponsorUniversity of Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-31

Contact for this trial

Luis R Torres, PhD

713-743-8512 LRTorres@uh.edu

View on ClinicalTrials.gov More Heroin Dependence trials

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Self-reported reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks.

Lab-based reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks. These are monitored continuously every 10th of a second.

Lab-based reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks. These are monitored continuously every 10th of a second.

Lab-based reactivity to cues

Timeframe: 3 hours (6 blocks of 3 minutes with time in between each block); this is done in two consecutive weeks. These are monitored continuously every 10th of a second.